Anne Marfaing‐Koka

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine

Raphaël Itzykson, Sylvain Thépot, Bruno Quesnel et al. · Blood · 2010 · 386 citations · Full text

Medicine, Oncology, Pharmacology +10

Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-<i>alpha</i> and inhibition by IL-4 and IL-13.

Anne Marfaing‐Koka, Odile Devergne, G Gorgone et al. · The Journal of Immunology · 1995 · 307 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Chemokine RANTES in Severe Pulmonary Arterial Hypertension

Peter Dorfmüller, Véronique Zarka, Ingrid Durand–Gasselin et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 292 citations

Veterinary Medicine, Cell Biology, Pathobiology +16

CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension

Karl Balabanian, Arnaud Foussat, Peter Dorfmüller et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 270 citations

Veterinary Medicine, Immunology, Pathobiology +15

Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells.

Odile Devergne, Anne Marfaing‐Koka, Thomas J. Schall et al. · The Journal of Experimental Medicine · 1994 · 221 citations · Full text

Life Sciences, Immunology, Pathology +17